The latest biotech news

alzheimers disease treatment vivoryon therapeutics

News and Trends 24 Oct 2019

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

The German company Vivoryon Therapeutics has raised €43M on Euronext Amsterdam to fund a phase IIb trial of a drug that could slow the progression of Alzheimer’s disease by blocking toxic forms of the protein amyloid-beta. Vivoryon Therapeutics, previously known as Probiodrug, raised the money using a rights offering and a private placement on Euronext […]

October 24, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 22 Oct 2019

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day treat the common condition bacterial vaginosis without disrupting the microbiome as traditional antibiotics do. The preclinical drug candidate is derived from a protein called an endolysin. Endolysins are made by bacteria-hunting viruses called bacteriophages and kill bacteria by rupturing the […]

October 22, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 21 Oct 2019

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

Update (21/10/2019): An extension of French biotech Abivax’s phase IIa trial shows its treatment for the inflammatory bowel disease ulcerative colitis has good efficacy after a year of treatment, with 75% of the screened patients remaining symptom-free. Of the 32 patients in the original phase IIa trial, 19 patients were treated with Abivax’s drug in […]

October 21, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Oct 2019

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies for solid tumors and blood cancer. Innate Pharma’s lead candidate antibody monalizumab is being co-developed in phase II with AstraZeneca for the treatment of head and neck cancer and colorectal cancer. Monalizumab is a member […]

October 17, 2019 - 2 minutesmins - By Jonathan Smith

cancer immunotherapy gammadelta therapeutics adaptate biotherapeutics

News and Trends 16 Oct 2019

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

The UK biotech GammaDelta Therapeutics has founded Adaptate Biotherapeutics to develop cancer immunotherapies based on antibodies that boost a rare type of immune cell. Adaptate Biotherapeutics is a spin-out of GammaDelta Therapeutics, a London company founded in 2016 that specializes in using a rare type of immune cells, known as gamma delta T-cells, to fight […]

October 16, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Oct 2019

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to launch an AI tool that reduces the time it takes to develop treatments for rare diseases by five years. The Series B round was led by the UK VC firm Atomico and includes the returning investor Jonathan Milner, the founder […]

October 16, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 15 Oct 2019

German Cancer Virotherapy Biotech Launches with €12M Series A

Abalos Therapeutics launches today with €12M in Series A funding to get the development of its arenavirus-based cancer therapies off the ground. Boehringer Ingelheim Venture Fund and Gründerfonds Ruhr co-led the investment round, with additional contributions from NRW.BANK and High-Tech Gründerfonds. Abalos, which is based in Essen, Germany, will focus on developing anti-cancer drugs with […]

October 15, 2019 - 2 minutesmins - By Helen Albert

20191008 Rheticus Evonik DEBO0495 freigegeben e1571095521515

News and Trends 15 Oct 2019

Artificial Photosynthesis-Driven Chemical Plant Launched in Germany

The German industrial giants Siemens and Evonik have launched a joint project to build and run a test plant to make valuable chemicals from water and waste carbon dioxide using bacteria — a process known as artificial photosynthesis. The test plant, which is currently under construction, will be based at Evonik’s site in Marl, Germany, […]

October 15, 2019 - 3 minutesmins - By Helen Albert

delft university Planet bio business incubator

News and Trends 14 Oct 2019

Dutch Incubator Launched to Scale up Industrial Biotechs

A collaboration involving the Dutch company DSM and other organizations in the Netherlands has launched Planet B.io, an incubator aimed at scaling up technology developed by industrial biotech startups such as the lab-grown meat developer Meatable. Planet B.io is based at the Biotech Campus Delft, the Netherlands, and contains a total of 3,000 m² of office […]

October 14, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Oct 2019

Mogrify Raises €15M Series A to Chase the ‘Holy Grail’ of Cell Therapy

Cambridge-based Mogrify has raised €14.5M to develop a technology that could allow scientists to transform any human cell into another cell type without the arduous process of turning them into a stem cell first. The Series A round was led by Ahren Innovation Capital, an investment firm founded by science entrepreneurs from the UK […]

October 14, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Oct 2019

Update: BioNTech Files for €141M Nasdaq IPO

BioNTech’s Nasdaq IPO has raised €141M ($155M), a lower sum than it initially anticipated. The timing of the IPO means it has likely been impacted by adverse market conditions, which are due to factors such as global manufacturing slowdowns and escalations in US and Chinese trade disputes. This same market volatility led several companies such […]

October 10, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

acne s biomedic skinbiotherapeutics skin microbiome

News and Trends 8 Oct 2019

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome

Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based on delivering live bacteria to the gut. The partners will develop vaccines against three undisclosed conditions. As well as an undisclosed upfront fee for each condition, 4D Pharma will be eligible to receive up to €316.5M ($347.5M) in developmental milestones. […]

October 8, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

Austrian Biotech Will Develop Viral Protein For Vaginal Infection

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech

UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI

German Cancer Virotherapy Biotech Launches with €12M Series A

Artificial Photosynthesis-Driven Chemical Plant Launched in Germany

Dutch Incubator Launched to Scale up Industrial Biotechs

Mogrify Raises €15M Series A to Chase the ‘Holy Grail’ of Cell Therapy

Update: BioNTech Files for €141M Nasdaq IPO

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!